SE434701B - Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa - Google Patents
Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosaInfo
- Publication number
- SE434701B SE434701B SE7601841A SE7601841A SE434701B SE 434701 B SE434701 B SE 434701B SE 7601841 A SE7601841 A SE 7601841A SE 7601841 A SE7601841 A SE 7601841A SE 434701 B SE434701 B SE 434701B
- Authority
- SE
- Sweden
- Prior art keywords
- interferon
- pseudomonas aeruginosa
- infection prevention
- make tumor
- inducing bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50055979A JPS51133489A (en) | 1975-05-14 | 1975-05-14 | Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7601841L SE7601841L (sv) | 1976-11-15 |
SE434701B true SE434701B (sv) | 1984-08-13 |
Family
ID=13014183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7601841A SE434701B (sv) | 1975-05-14 | 1976-02-18 | Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa |
Country Status (7)
Country | Link |
---|---|
US (1) | US4079126A (sv) |
JP (1) | JPS51133489A (sv) |
CA (1) | CA1060797A (sv) |
DE (1) | DE2610504C2 (sv) |
FR (1) | FR2311093A1 (sv) |
GB (1) | GB1537509A (sv) |
SE (1) | SE434701B (sv) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1085293A (en) * | 1976-02-05 | 1980-09-09 | Yuzuru Homma | Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof |
JPS5296729A (en) * | 1976-02-05 | 1977-08-13 | Shionogi & Co Ltd | Mixed vaccin for cyanomycosis |
US4479935A (en) * | 1980-04-22 | 1984-10-30 | Institut Pasteur | Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation |
CA1256370A (en) * | 1984-02-24 | 1989-06-27 | Yuzuru Homma | Toxoids of elastase of pseudomonas aeruginosa origin |
AT384032B (de) * | 1985-01-14 | 1987-09-25 | Immuno Ag | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
US5179001A (en) * | 1985-09-27 | 1993-01-12 | The Regents Of The University Of California | Detection and monitoring of chronic and gram-negative infection |
AT391080B (de) * | 1986-06-24 | 1990-08-10 | Immuno Ag | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen |
US5237053A (en) * | 1986-06-24 | 1993-08-17 | Immuno Aktiengesellschaft | Preparation active against Pseudomonas aeruginosa infections and methods of producing them |
FR2613380B1 (fr) * | 1987-04-06 | 1989-11-17 | Pasteur Institut | Nouvelle substance adjuvante de certains antimitotiques chimiques, procede d'obtention de cette substance a partir de cultures de vibrio cholerae, agents therapeutiques contenant ladite substance |
US6406696B1 (en) | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
WO1991006319A1 (en) * | 1989-10-27 | 1991-05-16 | Arch Development Corporation | Methods and compositions for promoting immunopotentiation |
US20030108548A1 (en) * | 1993-06-01 | 2003-06-12 | Bluestone Jeffrey A. | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
US6491916B1 (en) | 1994-06-01 | 2002-12-10 | Tolerance Therapeutics, Inc. | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
SG163615A1 (en) * | 2005-07-11 | 2010-08-30 | Macrogenics Inc | Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
AU2007260687B2 (en) * | 2006-06-14 | 2013-12-12 | Provention Bio, Inc. | Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity |
WO2008079713A2 (en) * | 2006-12-21 | 2008-07-03 | Macrogenics Inc. | Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
KR20190060879A (ko) * | 2011-03-02 | 2019-06-03 | 제롬 쉔타그 | 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단 |
CN109401992B (zh) * | 2017-08-18 | 2021-07-23 | 黑龙江省科学院微生物研究所 | 一株高产内毒素蛋白的铜绿假单胞菌及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS496096B1 (sv) * | 1970-09-30 | 1974-02-12 | ||
GB1365950A (en) * | 1970-10-20 | 1974-09-04 | Eisai Co Ltd | Pharmaceutical composition comprising a cell wall protein compo nent of pseudomonas aeruginosa |
FR2184531B1 (sv) * | 1972-05-19 | 1975-10-17 | Anvar |
-
1975
- 1975-05-14 JP JP50055979A patent/JPS51133489A/ja active Granted
-
1976
- 1976-02-16 GB GB5938/76A patent/GB1537509A/en not_active Expired
- 1976-02-18 SE SE7601841A patent/SE434701B/sv unknown
- 1976-02-26 CA CA246,619A patent/CA1060797A/en not_active Expired
- 1976-03-01 FR FR7605759A patent/FR2311093A1/fr active Granted
- 1976-03-12 DE DE2610504A patent/DE2610504C2/de not_active Expired
- 1976-03-19 US US05/668,564 patent/US4079126A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE2610504C2 (de) | 1985-07-11 |
US4079126A (en) | 1978-03-14 |
GB1537509A (en) | 1978-12-29 |
FR2311093A1 (fr) | 1976-12-10 |
FR2311093B1 (sv) | 1979-06-29 |
DE2610504A1 (de) | 1976-11-25 |
CA1060797A (en) | 1979-08-21 |
JPS6123167B2 (sv) | 1986-06-04 |
JPS51133489A (en) | 1976-11-19 |
SE7601841L (sv) | 1976-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE434701B (sv) | Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa | |
SE7610788L (sv) | Zeolit nu-1 och sett att framstella densamma | |
SE7611646L (sv) | Grundmassa och sett att framstella densamma | |
SE7602339L (sv) | Kinolonderivat och sett att framstella desamma | |
SE414268B (sv) | Muskelskelettknestodmuff och sett att framstella densamma | |
SE427527B (sv) | Rorformigt filterelement och sett att framstella det | |
SE7611761L (sv) | Sett att framstella modifierad polysackarid | |
SE424181B (sv) | Sett att framstella kulformiga aliminiumoxid- innehallande partiklar | |
SE7806122L (sv) | Kontaktlins och sett att framstella densamma | |
SE7601238L (sv) | Sett att behandla avlutar | |
SE7606265L (sv) | Panel och sett att framstella densamma | |
SE7607240L (sv) | Sett att framstella pyrrolettiksyraforeningar | |
SE425736B (sv) | Sett att framstella kromanon-(4) | |
FR2299761A1 (fr) | Montage d'amplificateur differentiel cmos utilis | |
SE7805269L (sv) | Azolyleterderivat till anvendning som fungicider och sett att framstella foreningarna | |
SE7607004L (sv) | Klisterremsa och sett att tillverka denna | |
SE421185B (sv) | Sett att framstella plastror med muff och plastror framstellt enligt settet | |
SE421695B (sv) | Sett att framstella piperazinylpyraziner | |
FR2311210A1 (fr) | Dispositif d'assemblage de deux pieces de bois | |
SE7608887L (sv) | Foreningar av cefalosporin-typ och sett att framstella desamma | |
SE7605650L (sv) | Diskmaskin och sett for att driva densamma | |
SE7601927L (sv) | Nya isocyanater och sett att framstella dessa | |
SE7801030L (sv) | Pentapeptidkompositioner och sett att framstella desamma | |
SE427559B (sv) | Sett att frastella 1-n-(alfa-substituerade-omega-aminoacyl)-3'-deoxiribostamyciner | |
SE7614107L (sv) | Depa-steroidestrar och sett att framstella desamma |